The role of chemotherapy in the management of the patient with T3b bladder cancer

Seminars in Urologic Oncology

Volumn 14, Issue 2, 1996, Pages 81-85

  Millikan, R ^a   Dinney, C P N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adjuvant; bladder cancer; chemotherapy; neoadjuvant

Indexed keywords

ALPHA INTERFERON; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; GALLIUM NITRATE; IFOSFAMIDE; VINBLASTINE;

BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; COMBINATION CHEMOTHERAPY; CYSTECTOMY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; CYSTECTOMY; HUMANS; NEOPLASM STAGING; PATIENT SELECTION; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0029997731     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)